We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Avacta Group plc (AVCT) Ordinary Shares 10p

Sell:49.50p Buy:50.00p 0 Change: 0.75p (1.53%)
FTSE AIM 100:0.26%
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Miscellaneous

Avacta Group plc Ordinary Shares 10p

Type:
Miscellaneous
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 28 Feb 2024)

What is happening?


Avacta Group (AVCT) have announced their intention to raise up to £26.8m via a Placing (for Institutional Investors) and a Retail Offer (for Individual Investors).

 

Avacta Group (AVCT) have decided not to issue a Prospectus as part of the fundraising. This means that the Retail Offer has been limited to the Sterling equivalent of €8 million and may only be open for a number of hours. It also means that information relating to the fundraising is limited to the Company announcement.

 

• Applications are due to close at 9am on Monday 04 March. Due to the nature of the fundraising, applications can close at any time and without prior warning.


• Shares are being offered at a fixed price of 50 pence.


• The minimum application for the Retail Offer is £50.


• By applying for shares in the Retail Offer you are deemed to have read, understood and agreed to the HL Retail Offer Risk Warnings, Terms and Conditions and the Company Announcement.


• Hargreaves Lansdown will receive 0.5% commission from the Issuer as part of the Offer.

 

What are my options?

 

 

Option 1 – Do Nothing. If you do not return an election by the deadline of 9am on Monday 04 March, the Offer will lapse.

 

Option 2 – You can choose to buy new Shares. If you wish to submit an order outside of the product you currently hold your shares, please leave a note in the comments section of the application.

 

When do I have to decide by?

 

Any instruction to participate in the Retail Offer must be received by 9am on Monday 04 March. If no instruction is received the Offer will lapse.

 

Before submitting an instruction, you should carefully read the Company Announcement, HL Retail Offer Risk Warnings & Terms and Conditions which are attached to the Retail Offer notification. You can find this in the Secure Messaging Centre of your online account. By submitting an instruction, you are deemed to have read and understood these documents as well as agreed to any terms within.

What happens after I apply?


If you apply for shares you will receive two Secure Messages. The first will confirm your application and be sent shortly after 11am on Monday 04 March. The second will confirm how many shares you have been allocated and be sent once the results have been announced.

 

You can view your application in the Pending Orders tab of your online account from midday on Tuesday 05 March.

Your new shares will be credited to your account on Tuesday 19 March. Please note admission is subject to approval of a resolution at the General Meeting expected to be convened on Monday 18 March. This may be delayed in the event the company does not deliver your shares to us by this time.

 

To assist the Company during the allocation process, we may be required to disclose the number of Avacta Group (AVCT) shares you hold with Hargreaves Lansdown. We will do this by calculating the shares held in your Hargreaves Lansdown account at the close of business on Tuesday 27 February.

 

It should be noted that a subscription for the Retail Shares and any investment in the company carry a number of risks. Investors should make their own investigations into the merits of an investment in the Company. This message is not personal advice and is a summary of the Avacta Group (AVCT) announcement.

 

If you require any assistance, please contact our Helpdesk on 0117 900 9000.

×
Sell:49.50p
Buy:50.00p
Change: 0.75p (1.53%)
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Miscellaneous

Avacta Group plc Ordinary Shares 10p

Type:
Miscellaneous
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 28 Feb 2024)

What is happening?


Avacta Group (AVCT) have announced their intention to raise up to £26.8m via a Placing (for Institutional Investors) and a Retail Offer (for Individual Investors).

 

Avacta Group (AVCT) have decided not to issue a Prospectus as part of the fundraising. This means that the Retail Offer has been limited to the Sterling equivalent of €8 million and may only be open for a number of hours. It also means that information relating to the fundraising is limited to the Company announcement.

 

• Applications are due to close at 9am on Monday 04 March. Due to the nature of the fundraising, applications can close at any time and without prior warning.


• Shares are being offered at a fixed price of 50 pence.


• The minimum application for the Retail Offer is £50.


• By applying for shares in the Retail Offer you are deemed to have read, understood and agreed to the HL Retail Offer Risk Warnings, Terms and Conditions and the Company Announcement.


• Hargreaves Lansdown will receive 0.5% commission from the Issuer as part of the Offer.

 

What are my options?

 

 

Option 1 – Do Nothing. If you do not return an election by the deadline of 9am on Monday 04 March, the Offer will lapse.

 

Option 2 – You can choose to buy new Shares. If you wish to submit an order outside of the product you currently hold your shares, please leave a note in the comments section of the application.

 

When do I have to decide by?

 

Any instruction to participate in the Retail Offer must be received by 9am on Monday 04 March. If no instruction is received the Offer will lapse.

 

Before submitting an instruction, you should carefully read the Company Announcement, HL Retail Offer Risk Warnings & Terms and Conditions which are attached to the Retail Offer notification. You can find this in the Secure Messaging Centre of your online account. By submitting an instruction, you are deemed to have read and understood these documents as well as agreed to any terms within.

What happens after I apply?


If you apply for shares you will receive two Secure Messages. The first will confirm your application and be sent shortly after 11am on Monday 04 March. The second will confirm how many shares you have been allocated and be sent once the results have been announced.

 

You can view your application in the Pending Orders tab of your online account from midday on Tuesday 05 March.

Your new shares will be credited to your account on Tuesday 19 March. Please note admission is subject to approval of a resolution at the General Meeting expected to be convened on Monday 18 March. This may be delayed in the event the company does not deliver your shares to us by this time.

 

To assist the Company during the allocation process, we may be required to disclose the number of Avacta Group (AVCT) shares you hold with Hargreaves Lansdown. We will do this by calculating the shares held in your Hargreaves Lansdown account at the close of business on Tuesday 27 February.

 

It should be noted that a subscription for the Retail Shares and any investment in the company carry a number of risks. Investors should make their own investigations into the merits of an investment in the Company. This message is not personal advice and is a summary of the Avacta Group (AVCT) announcement.

 

If you require any assistance, please contact our Helpdesk on 0117 900 9000.

×
Sell:49.50p
Buy:50.00p
Change: 0.75p (1.53%)
Market closed Prices as at close on 28 March 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Miscellaneous

Avacta Group plc Ordinary Shares 10p

Type:
Miscellaneous
Shareholder action required:
Yes
Status:
Update Pending
Details (last updated 28 Feb 2024)

What is happening?


Avacta Group (AVCT) have announced their intention to raise up to £26.8m via a Placing (for Institutional Investors) and a Retail Offer (for Individual Investors).

 

Avacta Group (AVCT) have decided not to issue a Prospectus as part of the fundraising. This means that the Retail Offer has been limited to the Sterling equivalent of €8 million and may only be open for a number of hours. It also means that information relating to the fundraising is limited to the Company announcement.

 

• Applications are due to close at 9am on Monday 04 March. Due to the nature of the fundraising, applications can close at any time and without prior warning.


• Shares are being offered at a fixed price of 50 pence.


• The minimum application for the Retail Offer is £50.


• By applying for shares in the Retail Offer you are deemed to have read, understood and agreed to the HL Retail Offer Risk Warnings, Terms and Conditions and the Company Announcement.


• Hargreaves Lansdown will receive 0.5% commission from the Issuer as part of the Offer.

 

What are my options?

 

 

Option 1 – Do Nothing. If you do not return an election by the deadline of 9am on Monday 04 March, the Offer will lapse.

 

Option 2 – You can choose to buy new Shares. If you wish to submit an order outside of the product you currently hold your shares, please leave a note in the comments section of the application.

 

When do I have to decide by?

 

Any instruction to participate in the Retail Offer must be received by 9am on Monday 04 March. If no instruction is received the Offer will lapse.

 

Before submitting an instruction, you should carefully read the Company Announcement, HL Retail Offer Risk Warnings & Terms and Conditions which are attached to the Retail Offer notification. You can find this in the Secure Messaging Centre of your online account. By submitting an instruction, you are deemed to have read and understood these documents as well as agreed to any terms within.

What happens after I apply?


If you apply for shares you will receive two Secure Messages. The first will confirm your application and be sent shortly after 11am on Monday 04 March. The second will confirm how many shares you have been allocated and be sent once the results have been announced.

 

You can view your application in the Pending Orders tab of your online account from midday on Tuesday 05 March.

Your new shares will be credited to your account on Tuesday 19 March. Please note admission is subject to approval of a resolution at the General Meeting expected to be convened on Monday 18 March. This may be delayed in the event the company does not deliver your shares to us by this time.

 

To assist the Company during the allocation process, we may be required to disclose the number of Avacta Group (AVCT) shares you hold with Hargreaves Lansdown. We will do this by calculating the shares held in your Hargreaves Lansdown account at the close of business on Tuesday 27 February.

 

It should be noted that a subscription for the Retail Shares and any investment in the company carry a number of risks. Investors should make their own investigations into the merits of an investment in the Company. This message is not personal advice and is a summary of the Avacta Group (AVCT) announcement.

 

If you require any assistance, please contact our Helpdesk on 0117 900 9000.

×
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Avacta Group plc is a life sciences company. The Company is focused on improving people's health and well-being through targeted oncology drugs and powerful diagnostics. It has two divisions: Diagnostics and Therapeutics. Its therapeutics division, which is a clinical-stage oncology drug developer, is building a wholly owned pipeline of novel Affimer immunotherapies and prelCISION tumour-targeted chemotherapies. Its lead program, AVA6000, is a prelCISION tumour-targeted form of the established chemotherapy doxorubicin. Its Affimer platform is a class of biotherapeutics based on a naturally occurring human protein. The Company’s prelCISION targeted chemotherapy platform releases active chemotherapy in the tumor, which limits the systemic exposure that causes damage to healthy tissues and thereby improves the overall safety and therapeutic potential of these anti-cancer treatments. The Company’s Diagnostics Division develops and supplies a range of in-vitro diagnostic (IVD) solutions.

Contact details

Address:
Unit 20, Ash Way
WETHERBY
LS23 7FA
United Kingdom
Telephone:
+44 (01904) 217070
Website:
https://avacta.com/

Important dates

Future events
There are no future events available.
Past events
General meeting 18 March 2024 18/03/24
Interim results 28 September 2023 28/09/23
AGM 28 June 2023 28/06/23
Annual report 02 June 2023 02/06/23
Final results 25 April 2023 25/04/23

General stock information

EPIC:
AVCT
ISIN:
GB00BYYW9G87
Market cap:
£174.38 million
Shares in issue:
350.51 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE AIM 100,FTSE AIM All Share

Key personnel

  • Alastair Smith
    Chief Executive Officer, Executive Director
  • Tony Gardiner
    Chief Financial Officer, Company Secretary, Executive Director
  • Christina Coughlin
    Non-Executive Director, Chief Medical Officer
  • Simon Bennett
    Chief Business Officer - Therapeutics

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.